Peddada Anuj V, Blasi Olivier C, White Gerald A, Monroe Alan T, Jennings Scott B, Gibbs Greg L
Penrose Cancer Center, Radiation Oncology, Colorado Springs, Colorado.
Penrose Cancer Center, Colorado Associates in Medical Physics, Colorado Springs, Colorado.
Pract Radiat Oncol. 2015 Jul-Aug;5(4):228-37. doi: 10.1016/j.prro.2014.11.004. Epub 2014 Dec 24.
We conducted a prospective study to evaluate needle displacements between prostate high-dose-rate (HDR) brachytherapy fractions and offer technical recommendations to help prevent displacements from the outset.
Planning computed tomography and verification computed tomography scans were obtained at 1-mm slice thickness and prospectively assessed for interfraction needle movement for each fraction of a 2-fraction HDR prostate boost. For both the planning and verification CTs, distances from each needle tip to the centroid of 3 implanted prostate gold seeds were measured. We determined the mean and range of the displacement distances.
Thirty-three consecutive patients (66 fractions, 540 needle-pair positions for a total of 1080 needles) were evaluated for changes in the length between the needle tip and centroid displacement. Overall, only 0.2% of the needles had any change greater than 3.5 mm between the needle tip and centroid. The mean amount of displacement was 0.97 mm, with a standard deviation of 0.76 mm. Among the patients, no fraction had more than 1 needle with a variation greater than 3.0 mm.
Needle displacements in HDR prostate brachytherapy have been reported by numerous institutions using various techniques. We report the first study to demonstrate needle displacement of less than 1 mm on average, and we describe our process of care surrounding the implantation.